Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Gross Profit (2016 - 2025)

Standard Biotools (LAB) has disclosed Gross Profit for 16 consecutive years, with $11.4 million as the latest value for Q4 2025.

  • Quarterly Gross Profit changed 0.22% to $11.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.2 million through Dec 2025, down 11.73% year-over-year, with the annual reading at $42.5 million for FY2025, 5.21% down from the prior year.
  • Gross Profit for Q4 2025 was $11.4 million at Standard Biotools, up from $9.5 million in the prior quarter.
  • The five-year high for Gross Profit was $29.2 million in Q2 2021, with the low at $4.4 million in Q2 2022.
  • Average Gross Profit over 5 years is $15.1 million, with a median of $12.1 million recorded in 2024.
  • The sharpest move saw Gross Profit tumbled 84.81% in 2022, then soared 207.25% in 2023.
  • Over 5 years, Gross Profit stood at $27.0 million in 2021, then tumbled by 58.63% to $11.2 million in 2022, then increased by 19.61% to $13.4 million in 2023, then fell by 14.97% to $11.4 million in 2024, then increased by 0.22% to $11.4 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $11.4 million, $9.5 million, and $10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.